Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimuvax in pre-operative primary breast cancer
2011-004822-85Phase 2Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics, Peptides, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Standard of care alone with Stimuvax plus standard of care (2 arms). Primary endpoint: Residual cancer burden response. Started Nov 2011; status: completed.
02
Drugs
tecemotide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-004822-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004822-85.